Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Enveric Biosciences stocks are traded under the ticker SLZ0.STU.
When is the next Enveric Biosciences earnings date?▼
Enveric Biosciences is going to release the next earnings report on May 19, 2026.
What were Enveric Biosciences earnings last quarter?▼
SLZ0.STU earnings for the last quarter are 0.74 EUR per share, whereas the estimation was -48.47 EUR resulting in a +101.52% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Enveric Biosciences pay dividends?▼
Yes, SLZ0.STU dividends are paid en. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Enveric Biosciences have?▼
As of April 29, 2026, the company has 7 employees.
In which sector is Enveric Biosciences located?▼
Enveric Biosciences operates in the Health & Wellness sector.
When did Enveric Biosciences complete a stock split?▼
Enveric Biosciences has not had any recent stock splits.
Where is Enveric Biosciences headquartered?▼
Enveric Biosciences is headquartered in Naples, United States.